CICON-23, 20-23 September, Milan Italy Doroteya Raykova will present our poster Unraveling the tumor microenvironment with spatial proteomics: in situ detection of immune checkpoint interactions in cancer patient tissues (PDF) at the CICON-23 Conference. Inge Cyrén, Area Manager for North America will also be representing Navinci. Please reach out to them if you want to book a…
Expanding Your Options with NaveniLink™ Would you like to perform a proximity ligation assay using your own primary antibodies? Our NaveniLink conjugation kit allows you to do just that. You can use your primary antibodies and easily conjugate them with our proprietary oligonucleotide sequences. These conjugates can be seamlessly integrated into our Naveni® product line,…
Product Advancement: NaveniFlex™ Cell We know that diverse sample types demand tailored solutions. To maximize the value of your samples, we refined and optimized our Flexible offerings and aligned them closer to your needs. Introducing NaveniFlex Cell, an optimized advancement that builds upon the strong foundation of our NaveniFlex™ technology. This cutting-edge kit is meticulously…
NaveniFlex in Autophagy publication We’re excited to see that our Naveni® technology has been referenced in a fantastic publication describing novel insights into the process of lysosomal degradation of mitochondria (mitophagy) (Godtliebsen et al. 2023, Autophagy). The authors used ingenious double tagging of mitochondria, where the green signal was quenched at low pH, whereas red…
Cayman and Navinci Announce Strategic Partnership Expanding Access to Next-Generation Tools for Spatial Proteomics Ann Arbor, MI – 07/05/2023 – Global life sciences supplier Cayman Chemical (Cayman) announced today a strategic partnership with Navinci Diagnostics (Navinci), a Swedish biotechnology company developing innovative tools for spatial proteomics. This partnership expands access to Navinci’s portfolio of proximity…